High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids

Journal of Virology

Volumn 74, Issue 24, 2000, Pages 11456-11463

  Cao, L ^a   Liu, Y ^a   During, M J ^a   Xiao, W ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANTIBODY TITER; ARTICLE; GENE EXPRESSION; GENE TRANSFER; GENOME; HYBRIDIZATION; IMMUNE RESPONSE; INTRON; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE;

DEPENDOVIRUS; GENETIC VECTORS; HUMANS; INTRONS; PLASMIDS; RECOMBINATION, GENETIC; TRANSFECTION;

EID: 0034469127     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.24.11456-11463.2000     Document Type: Article

References (34)

1. Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production
2. Biology of adeno-associated virus
3. Introns increase transcriptional efficiency in transgenic mice
4. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses
5. Cell lines for the production of recombinant adeno-associated virus
6. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors
7. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap
8. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus
9. Structural analysis of adeno-associated virus transduction circular intermediates
10. A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation
11. Peroral gene therapy of lactose intolerance using an adeno-associated virus vector
12. An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction
13. Adeno-associated virus vectors for gene therapy of cystic fibrosis
14. High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus
15. Titration of AAV-2 particles via a novel capsid ELISA: Packaging of genomes can limit production of recombinant AAV-2
16. Novel tools for production and purification of recombinant adenoassociated virus vectors
17. Use of adeno-associated virus as a mammalian DNA cloning vector: Transduction of neomycin resistance into mammalian tissue culture cells
18. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector
19. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
20. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination
21. Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter
22. Site-specific integration by adeno-associated virus
23. Role for highly regulated rep gene expression in adeno-associated virus vector production
24. Use of adeno-associated virus as a general transduction vector for mammalian cells
25. Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors
26. Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression
27. Targeted integration of adeno-associated virus (AAV) into human chromosome 19
28. Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization
29. Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination
30. Adeno-associated virus as a vector for liver-directed gene therapy
31. Gene therapy vectors based on adeno-associated virus type 1
32. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
33. Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination